INBX
Inhibrx Biosciences Inc
NASDAQ · Biotechnology
$83.91
+2.38 (+2.92%)
Open$83.22
Previous Close$81.53
Day High$84.98
Day Low$81.35
52W High$94.57
52W Low$10.81
Volume—
Avg Volume225.6K
Market Cap1.22B
P/E Ratio—
EPS$-7.22
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
-78.4% upside
Current
$83.91
$83.91
Target
$18.13
$18.13
$12.39
$18.13 avg
$27.56
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 193.4K | 639.7K | 390.65M |
| Net Income | 1.64B | 4.87B | -113,394,480 |
| Profit Margin | 843,786.0% | 801,596.7% | -29.0% |
| EBITDA | 1.64B | 5.16B | -167,670,996 |
| Free Cash Flow | — | — | -86,634,001 |
| Rev Growth | -69.8% | -69.8% | +1.5% |
| Debt/Equity | — | — | 0.12 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |